Get all your news in one place.

100’s of premium titles.
One app.

Start reading

Get all your news in one place.

100’s of premium titles. One news app.

Start reading

The Latest Breaking News from BioNTech

BioNTech Nears A Sell Signal After Cutting Outlook Despite Massive Sales Beat

BioNTech stock reversed lower Monday after the company cut its outlook for the year, despite walloping sales estimates.

Investors Business Daily

As Stock Market Awaits Election, Palantir, S&P 500 Nuke Leaders Report

Amid the election, and a Fed rate vote, earnings season roars ahead.

Investors Business Daily

How BioNTech, Up 26% Over Four Days, Is Riding Summit's Coattails To A Recovery

BioNTech stock has climbed 26% over four days as the German biotech rides a round of cancer treatment success from Summit Therapeutics.

Investors Business Daily

From analysis to the latest developments in health,
read the most diverse news in one place.

Mpox crisis: Why do African countries struggle to make or buy vaccines?

African countries produce less than 2 percent of the vaccines the continent needs, experts say.

Al Jazeera

World-first lung cancer vaccine trials launched across seven countries

First patient in UK gets dose of jab designed to kill most common form of lung cancer – and stop it coming back

The Guardian - UK

Lung cancer vaccine: Breakthrough jab could improve survival rates

The vaccine, known as BNT116, utilises messenger RNA (mRNA), the same technology used in the Covid jab

The Independent UK

Lung cancer vaccine: How does it work?

The first UK patient received the jab at the National Institute for Health Research UCLH Clinical Research Facility on Tuesday.

The Independent UK

Read news from The Economist, FT, and more,
with one subscription

Pfizer Slides Toward Sell Zone After BioNTech-Tied Covid/Flu Shot Misses Its Mark

Pfizer stock toppled Friday after the pharma giant reported mixed results for its BioNTech-partnered combination flu and Covid vaccine.

Investors Business Daily

NHS patients in England to be offered trials for world-first cancer vaccine

Jab personalised for individual’s tumours hailed as ‘gamechanger’ amid high hopes of stopping disease returning

The Guardian - UK

The Fight Against Cancer Enters a New Phase

Breakthrough treatments hold promise for patients and investors.

Kiplinger

BioNTech Lifts As Covid Sales Plummet With 90% Of Revenue Still To Come

BioNTech stock lifted a fraction Monday after Covid vaccine sales dropped again in the first quarter, amid wide losses.

Investors Business Daily

InstaDeep CEO Takes AI From Tunis To London

Karim Beguir launched the artificial intelligence start-up InstaDeep in Tunisia in 2014 with just two computers and $2,000.

International Business Times

Biontech Receives Notice Over Default On COVID Vaccine Royalties

BioNTech faces default notice from NIH over COVID vaccine royalties, raising concerns about ongoing pandemic response.

Top News

Breathtaking BioNTech Projections Reveal Revenue Rebound by 2025!

BioNTech envisions a bright future as it predicts a revival in revenue growth by 2025. Get ready for a thrilling comeback that will reshape the biotech lan...

International Business Times

Pfizer Sues Poland And Hungary Over Covid Debts

Pharmaceutical firms Pfizer and BioNTech are suing the governments of Poland and Hungary alleging they failed to pay for vaccines ordered during the Covid pandemic, lawyers said Tuesday.

The Guardian - UK

UK will not return to Cameron era’s close ties with China, Sunak says

At summit to drum up foreign investment PM says he does not intend to change policy towards Beijing

Get all your
news in one place.

100’s of premium titles.
One news app.

Investors Business Daily

Stock Market Rally Pauses As Yields Rebound; Datadog, Affirm Among Earnings Winners: Weekly Review

The stock market rally erased weekly gains as the major indexes ended long win streaks amid rebounding yields. Datadog led earnings winners.

Investors Business Daily

Eli Lilly, Power Generators Lead Top S&P 500 Performers Monday

Eli Lilly was an S&P 500 top performer Monday, while energy plays were among the day's biggest winners and losers.

Investors Business Daily

Stock Market Strolls Along; Vacation Stock Gains 100%; Warren Buffett's Stock Slumps

The small-cap Russell 2000 sinks while the major indexes hold steady. Warren Buffett's Berkshire Hathaway stock reacts after the company reported earnings on Saturday.

Investors Business Daily

BioNTech Stock Surges On Surprise Profit, Strong Sales. But Report Has Downside.

BioNTech unexpectedly reported a third-quarter profit and better-than-expected sales on Monday, pushing BNTX stock higher.

Investors Business Daily

Pfizer Hikes Paxlovid Price To $1,390 — More Than Double What The Government Paid

Pfizer is hiking its Paxlovid price to $1,390 for a five-day course of the Covid pill. But Pfizer stock fell early Thursday.

Investors Business Daily

Moderna, BioNTech Lead Covid Sell-Off After Pfizer Slashes Its Outlook By $9 Billion

Moderna stock and BioNTech stock led a sell-off Monday among Covid vaccine makers after Pfizer slashed its full-year guidance.

The Independent UK

University of Pennsylvania slammed for celebrating Nobel prize of vaccine researcher it once demoted

University once reportedly discouraged Katalin Karikó from pursuing mRNA research that later helped create Covid vaccines

1 2 3 4 5

People

From analysis to the latest developments in health,
read the most diverse news in one place.

Organisations